Substance / Medication

Fluoxetine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis.
Archer Charlotte, Wiles Nicola, Kessler David et al. · J Affect Disord · 2025
PMID: 39271062Meta-Analysis
Panic disorder during pregnancy and the first three years after delivery: a systematic review.
Verhees F Gerrik, Bendau Antonia, Unger Stefanie et al. · BMC Pregnancy Childbirth · 2025
PMID: 39825251Meta-AnalysisFull text (PMC)
Schizophrenia spectrum disorders with comorbid panic: A systematic review.
Veras André Barciela, Ribeiro Karyson Macruz, Peixoto Clayton et al. · Schizophr Res · 2025
PMID: 40010006Meta-Analysis
Panic Disorder in Patients With Vestibular Dysfunction: A Systematic Review and Meta-analysis.
McCray Lauren R, Kim Cory H, Nguyen Shaun A et al. · Otol Neurotol · 2025
PMID: 40210233Meta-Analysis
Hospital Anxiety and Depression Scale Anxiety subscale (HADS-A) for detecting anxiety disorders in adults.
Fomenko Alexey, Dümmler Daniel, Aktürk Zekeriya et al. · Cochrane Database Syst Rev · 2025
PMID: 40600405Meta-AnalysisFull text (PMC)
Pharmacological effects on 35% COpanic induction: A meta-analysis.
de Vos Jette H, Haj Yahya Alissa, Viechtbauer Wolfgang et al. · J Psychopharmacol · 2025
PMID: 41158004Meta-AnalysisFull text (PMC)
Neurochemical and genetic factors in panic disorder: a systematic review.
Moraes Adriana Carvalho Natal, Wijaya Clarissa, Freire Rafael et al. · Transl Psychiatry · 2024
PMID: 39025836Meta-AnalysisFull text (PMC)
Association between 5-HT1A receptor C-1019G, 5-HTTLPR polymorphisms and panic disorder: a meta-analysis.
Zhu Wenli, Bu Yangying, Wu Lijuan et al. · Aging (Albany NY) · 2024
PMID: 39207450Meta-AnalysisFull text (PMC)
Clinical serum metabolomics study on fluoxetine hydrochloride for depression.
Shen Dandan, Zhao Huan, Gao Shan et al. · Neurosci Lett · 2021
PMID: 33352278Trial
Bioequivalence study of fluoxetine hydrochloride in healthy volunteers.
Keller Thomas, Cambon Nathalie, Genevray Magali et al. · Arzneimittelforschung · 2005
PMID: 16229112Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fluoxetine hydrochloride (substance)
SNOMED CT
75115009
UMLS CUI
C0733380

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Fluoxetine hydrochloride: Uses, Evidence & Side Effects | Ltrl